We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Insights Into Tilray Brands (TLRY) Q1: Wall Street Projections for Key Metrics
Read MoreHide Full Article
In its upcoming report, Tilray Brands, Inc. (TLRY - Free Report) is predicted by Wall Street analysts to post quarterly loss of $0.05 per share, reflecting an increase of 50% compared to the same period last year. Revenues are forecasted to be $216.47 million, representing a year-over-year increase of 22.3%.
The current level reflects a downward revision of 24.4% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
Bearing this in mind, let's now explore the average estimates of specific Tilray Brands metrics that are commonly monitored and projected by Wall Street analysts.
Analysts forecast 'Revenues- Cannabis business' to reach $72.77 million. The estimate suggests a change of +3.5% year over year.
Based on the collective assessment of analysts, 'Revenues- Wellness business' should arrive at $14.29 million. The estimate indicates a year-over-year change of +7.5%.
The consensus among analysts is that 'Revenues- Beverage alcohol business' will reach $64.31 million. The estimate suggests a change of +166.2% year over year.
The collective assessment of analysts points to an estimated 'Revenues- Distribution business' of $67.34 million. The estimate points to a change of -2.6% from the year-ago quarter.
Shares of Tilray Brands have experienced a change of +4.3% in the past month compared to the +4.3% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), TLRY is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Insights Into Tilray Brands (TLRY) Q1: Wall Street Projections for Key Metrics
In its upcoming report, Tilray Brands, Inc. (TLRY - Free Report) is predicted by Wall Street analysts to post quarterly loss of $0.05 per share, reflecting an increase of 50% compared to the same period last year. Revenues are forecasted to be $216.47 million, representing a year-over-year increase of 22.3%.
The current level reflects a downward revision of 24.4% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.
Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.
While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.
Bearing this in mind, let's now explore the average estimates of specific Tilray Brands metrics that are commonly monitored and projected by Wall Street analysts.
Analysts forecast 'Revenues- Cannabis business' to reach $72.77 million. The estimate suggests a change of +3.5% year over year.
Based on the collective assessment of analysts, 'Revenues- Wellness business' should arrive at $14.29 million. The estimate indicates a year-over-year change of +7.5%.
The consensus among analysts is that 'Revenues- Beverage alcohol business' will reach $64.31 million. The estimate suggests a change of +166.2% year over year.
The collective assessment of analysts points to an estimated 'Revenues- Distribution business' of $67.34 million. The estimate points to a change of -2.6% from the year-ago quarter.
View all Key Company Metrics for Tilray Brands here>>>
Shares of Tilray Brands have experienced a change of +4.3% in the past month compared to the +4.3% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), TLRY is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>